Home » Newsletters » BioWorld Asia

BioWorld Asia

April 5, 2000

View Archived Issues

MediGene, Schering Align In $52M Deal For HPV Vaccine

Researchers Identify Peptide That Triggers Celiac Disease

Celltech Buys U.S.-Based Cistron, Gains Access To IL-1 Technology

November AG Taking Program Public On Market In Germany

SR Pharma Sees Additional Positive Data From SRL172

Mologen Starts Phase II/III Cancer Gene Therapy Trial

Israeli Researchers Show Toxic Shock Antidote Works In Mice

Australian Stocks Doing Well, But Lag Behind U.S. Counterparts

Peptide Therapeutics In Talks With Potential Company Buyer

Transghne Obtains U.S. Patent Covering Adenovirus Technique

DevCo Licenses Lexipafant, Marking Third Deal In A Month

Cambridge Antibody Raises #90M In Scaled-Back Offering

Teva To Market Bio-Tropin As Part Of $20M BTG Deal

Other News To Note

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for Dec. 19, 2025.
Today's news in brief
BioWorld MedTech
BioWorld MedTech briefs for Dec. 19, 2025.
HIV research is close to a cure but far from ending the pandemic
BioWorld
Advances in antiretroviral therapy (ART) now allow people living with HIV to lead normal lives with undetectable and nontransmissible levels of the virus in their...
Apollo’s APL-4098 shows potent antileukemic effects
BioWorld Science
Apollo Therapeutics Ltd. has developed APL-4098, a small-molecule general control nonderepressible 2 (GCN2) inhibitor for the potential treatment of AML.
ABS-1230 controls seizures in KCNT1-driven severe epilepsy
BioWorld Science
Mutations in the KCNT1 gene produce gain-of-function effects that lead to overactivation of the potassium channel and consequent disruption of normal neuronal...